Genmab
The Director, Global Medical Affairs Strategy – Solid Tumors leads the development and execution of global medical affairs strategy for oncology assets, with a focus on solid tumors. The role aligns scientific and commercial objectives, supports asset life-cycle management, and builds relationships with global thought leaders. The Director partners cross-functionally across medical, clinical operations, commercial and HEOR to drive data generation, medical planning, and scientific communication.
Headquarters
Valby, Hovedstaden, Denmark
Company Size
1001-5000 employees
Founded
1999
Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genmab.
Genmab Updates Share Buy-Back Program and Corrects Accumulated Purchase Figures
3 days ago
Head of Solid Tumors US Medical Affairs Oncology
BioLife Plasma Services
Director/ Sr. Director, Regulatory Affairs (Strategy, Oncology – Solid Tumors)
Nurix
Associate Director, Scientific Communications Lead, Solid Tumors, Global Medical Affairs Oncology
Takeda Pharmaceutical Company Limited
Medical Science Liaison, Pipeline Solid Tumors - Canada West
GSK plc
Senior Medical Director, Oncology Clinical Development (Solid Tumors)
AbbVie
Senior Medical Director, Oncology Clinical Development (Solid Tumors)
AbbVie